These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7219722)

  • 41. Identification of D-2 dopaminergic receptors in bovine adrenal cortex.
    Missale C; Liberini P; Memo M; Carruba MO; Spano P
    Life Sci; 1985 Dec; 37(26):2539-48. PubMed ID: 4079661
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dopamine denervation does not alter in vivo 3H-spiperone binding in rat striatum: implications for external imaging of dopamine receptors in Parkinson's disease.
    Bennett JP; Wooten GF
    Ann Neurol; 1986 Apr; 19(4):378-83. PubMed ID: 3707090
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of calmodulin on catecholamine-linked adenylate cyclase activity in rat striatum and cerebral cortex.
    Gnegy ME; Hultin T; Treisman G
    Adv Biochem Psychopharmacol; 1980; 21():125-31. PubMed ID: 6246737
    [No Abstract]   [Full Text] [Related]  

  • 44. Analysis of [3H]spiperone binding sites in the rat striatum and frontoparietal cortex by means of quantitative receptor autoradiography after inactivation of dopamine receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo: selective protection by sulpiride in the striatum.
    Fuxe K; Meller E; Goldstein M; Benfenati F; Agnati LF
    Neurosci Lett; 1986 Feb; 64(2):163-8. PubMed ID: 3960398
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Robust modulation of [3H]dopamine release from rat striatal slices by D-2 dopamine receptors.
    Dwoskin LP; Zahniser NR
    J Pharmacol Exp Ther; 1986 Nov; 239(2):442-53. PubMed ID: 3772803
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [3H] (-)sulpiride binding in rat striatum, cortex and anterior pituitary: an improved assay.
    Stefanini E; Ortu AM; Vernaleone F; Gessa GL
    Pharmacol Res Commun; 1987 Nov; 19(11):777-91. PubMed ID: 3444842
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Substantia nigra 6-hydroxydopamine lesions alter dopaminergic synaptic markers in the nucleus basalis magnocellularis and striatum of rats.
    Geula C; Slevin JT
    Synapse; 1989; 4(3):248-53. PubMed ID: 2532792
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [125I]iodopride: a specific high affinity radioligand for labelling striatal dopamine D-2 receptors.
    Janowsky A; De Paulis T; Clanton JA; Smith HE; Ebert MH; Kessler RM
    Eur J Pharmacol; 1988 May; 150(1-2):203-5. PubMed ID: 3402540
    [No Abstract]   [Full Text] [Related]  

  • 49. Sodium-dependent interaction of benzamides with dopamine receptors.
    Stefanini E; Marchisio AM; Devoto P; Vernaleone F; Collu R; Spano PF
    Brain Res; 1980 Sep; 198(1):229-33. PubMed ID: 7407589
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quantitative assessment of heterogeneous 3H-spiperone binding to rat neostriatum and frontal cortex.
    Howlett DR; Nahorski SR
    Life Sci; 1980 Feb; 26(7):511-7. PubMed ID: 7366332
    [No Abstract]   [Full Text] [Related]  

  • 51. Synthesis and binding properties of the fluorinated substituted benzamide [3H]NCQ 115, a new selective dopamine D2 receptor ligand.
    Hall H; Högberg T; Halldin C; Bengtsson S; Wedel I
    Eur J Pharmacol; 1991 Aug; 201(1):1-10. PubMed ID: 1686586
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Regulation of neurotensin-containing neurons in the rat striatum. Effects of unilateral striatal lesions with quinolinic acid and ibotenic acid on neurotensin content and its binding site density.
    Masuo Y; Montagne MN; Pélaprat D; Scherman D; Rostène W
    Brain Res; 1990 Jun; 520(1-2):6-13. PubMed ID: 2169955
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Detection of multiple receptors for dopamine.
    Spano PF; Memo M; Stefanini E; Fresia P; Trabucchi M
    Adv Biochem Psychopharmacol; 1980; 21():243-51. PubMed ID: 7376971
    [No Abstract]   [Full Text] [Related]  

  • 54. Evidence for different states of the dopamine D1 receptor: clozapine and fluperlapine may preferentially label an adenylate cyclase-coupled state of the D1 receptor.
    Andersen PH; Braestrup C
    J Neurochem; 1986 Dec; 47(6):1822-31. PubMed ID: 2945903
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Changes in striatal specific 3-H-atropine binding after unilateral 6-hydroxydopamine lesions of nigrostriatal dopaminergic neurones.
    Kato G; Carson S; Kemel ML; Glowinski J; Giorguieff MF
    Life Sci; 1978 May; 22(18):1607-14. PubMed ID: 353416
    [No Abstract]   [Full Text] [Related]  

  • 56. Dopamine efflux from striatum after chronic nicotine: evidence for autoreceptor desensitization.
    Harsing LG; Sershen H; Lajtha A
    J Neurochem; 1992 Jul; 59(1):48-54. PubMed ID: 1351932
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A comparative study of [3H]haloperidol and [3H]spiroperidol binding to receptors on rat cerebral membranes.
    Howlett DR; Nahorski SR
    FEBS Lett; 1978 Mar; 87(1):152-6. PubMed ID: 631328
    [No Abstract]   [Full Text] [Related]  

  • 58. 3H-apomorphine labels both dopamine postsynaptic receptors and autoreceptors.
    Sokoloff P; Martres MP; Schwartz JC
    Nature; 1980 Nov; 288(5788):283-6. PubMed ID: 7432527
    [TBL] [Abstract][Full Text] [Related]  

  • 59. ADTN (2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene): a prototype for possible dopaminergic false transmitters?
    Roberts PJ; Davis A
    Adv Biochem Psychopharmacol; 1978; 19():177-91. PubMed ID: 696460
    [No Abstract]   [Full Text] [Related]  

  • 60. Striatal D1- and D2-dopamine receptor sites are separately detectable in vivo.
    Leslie CA; Bennett JP
    Brain Res; 1987 Jul; 415(1):90-7. PubMed ID: 2957025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.